TNF and urinary bladder cancer: First, we only conducted bioinformatics analysis and qPCR without performing histological, cytological, or animal experiments to validate the regulation of the TNF signaling pathway in bladder cancer cells by Disitamab Vedotin in vivo and in vitro.